Global Adenomyosis treatment market segmentation on the basis of type (Focal, Adenomyoma, Diffuse and others), by diagnosis (Endometrial biopsy, Ultrasound, Magnetic resonance imaging (MRI), and others) Forecast 2023 - iCrowdNewswire
  • Spain
  • Brazil
  • Russia
  • France
  • Germany
  • China
  • Korea
  • Japan
 

Mar 14, 2018 2:00 PM ET

Global Adenomyosis treatment market segmentation on the basis of type (Focal, Adenomyoma, Diffuse and others), by diagnosis (Endometrial biopsy, Ultrasound, Magnetic resonance imaging (MRI), and others) Forecast 2023

iCrowdNewswire - Mar 14, 2018

 

Global Adenomyosis Treatment also known as Endometriosis interna, Adenomyosis uteri, Endometriosis uterine, or Adenomyometritis. Adenomyosis disorder occurs when endometrial tissue of the uterus endometrial cavity to grow into the uterus muscle that damage the uterine wall the uterine wall grow thicker. The Global Adenomyosis Treatment market is growing at the CAGR of ~4.1% during the forecast period and expected to reach US$ 291.5 million by 2023.

Some of the key players in this market are: Bayer AG (Germany), Ferring B.V. (Switzerland), Johnson & Johnson Consumer Inc. (US), Novartis (Switzerland), Merck KGaA (Germany), Pfizer Inc. (US), Speciality European Pharma (UK)

Sample Report Available @ https://www.marketresearchfuture.com/sample_request/3222 .

Targeted Audience

  1. Adenomyosis Treatment drugs manufacturers
  2. Adenomyosis Treatment drugs providers
  3. Hospitals and clinics
  4. Medical Research laboratories
  5. Research and Development (R&D) Companies
  6. Market Research and Consulting Service Providers
  7. Potential Investors

Global adenomyosis treatment Market has been segmented on the basis of type which Focal, Adenomyoma, Diffuse, and others. On the basis of diagnosis, it is segmented into endometrial biopsy, ultrasound (transabdominal, transvaginal/endovaginal), and magnetic resonance imaging (MRI). On the basis of treatment, the market is segmented into anti-inflammatory drugs (ibuprofen, Motrin IB, Advil, and others), hormone medications (Gonadotropin-releasing hormone (GnRH) agonists, Aromatase inhibitors), Hysterectomy (supracervial or subtotal hysterectomy, Total hysterectomy, Radical hysterectomy), and others.

Increasing prevalence of adenomyosis is leading the market growth. Rising prevalence of adenomyosis disorder is key factor for the market growth. Increasing knowledge about the disorder and treatment, new drugs and therapies, and advanced medical technology are major driving forces of the global adenomyosis market. Increasing funding for R&D to develop more advanced product for the market is another key driver for the market.

Table of Content:

  1. Report Prologue
  2. Introduction
  3. Research Methodology
  4. Market Dynamics
  5. Market Factor Analysis
  6. Global Adenomyosis Treatment Market By Type
  7. Global Adenomyosis Treatment Market By Diagnosis
  8. Global Adenomyosis Treatment Market By Treatment
  9. Global Adenomyosis Treatment Market By Region
  10. Competitive Landscape

Get Discount @ https://www.marketresearchfuture.com/check-discount/3222 .

About US: Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us: Market Research Future Office No. 528,

Amanora Chambers Magarpatta Road,

Hadapsar, Pune – 411028Maharashtra, India

Phone: +1 646 845 9312

Email: [email protected]

Contact Information:

Contact Us: Market Research Future Office No. 528,
Amanora Chambers Magarpatta Road,
Hadapsar, Pune - 411028Maharashtra, India
Phone: +1 646 845 9312
Email: [email protected]

View Related News >